Ceridian HCM Holding Inc (NYSE:CDAY) – Stock analysts at Piper Jaffray Companies decreased their Q4 2018 EPS estimates for shares of Ceridian HCM in a research report issued to clients and investors on Monday, October 29th, according to Zacks Investment Research. Piper Jaffray Companies analyst A. Zukin now expects that the company will post earnings per share of $0.09 for the quarter, down from their previous forecast of $0.15. Piper Jaffray Companies also issued estimates for Ceridian HCM’s Q2 2019 earnings at $0.09 EPS, Q3 2019 earnings at $0.11 EPS, Q4 2019 earnings at $0.18 EPS, FY2019 earnings at $0.49 EPS, Q1 2020 earnings at $0.18 EPS, Q2 2020 earnings at $0.18 EPS and Q3 2020 earnings at $0.20 EPS.
Ceridian HCM (NYSE:CDAY) last released its quarterly earnings data on Monday, October 29th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Ceridian HCM had a negative net margin of 2.25% and a positive return on equity of 2.64%. The business had revenue of $179.60 million during the quarter, compared to analyst estimates of $176.29 million. The firm’s quarterly revenue was up 9.8% compared to the same quarter last year.
CDAY has been the subject of a number of other reports. Canaccord Genuity reiterated a “hold” rating and issued a $36.00 price objective on shares of Ceridian HCM in a research note on Friday, August 10th. Zacks Investment Research lowered shares of Ceridian HCM from a “buy” rating to a “hold” rating in a research report on Wednesday, October 31st. Credit Suisse Group assumed coverage on shares of Ceridian HCM in a research report on Friday, October 5th. They set a “neutral” rating and a $45.00 price target for the company. Barclays boosted their price target on shares of Ceridian HCM from $35.00 to $36.00 and gave the company an “equal weight” rating in a research report on Friday, September 7th. Finally, William Blair upgraded shares of Ceridian HCM from a “market perform” rating to an “outperform” rating in a research report on Friday, August 10th. Nine investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $39.86.
Ceridian HCM stock traded up $0.26 during mid-day trading on Wednesday, reaching $36.34. The company’s stock had a trading volume of 1,137,934 shares, compared to its average volume of 1,304,186. Ceridian HCM has a 12-month low of $28.65 and a 12-month high of $44.98. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.43.
In other news, Director Cannae Holdings, Inc. sold 4,396,694 shares of Ceridian HCM stock in a transaction on Friday, November 16th. The shares were sold at an average price of $34.70, for a total transaction of $152,565,281.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Arthur Gitajn sold 135,755 shares of Ceridian HCM stock in a transaction on Tuesday, October 23rd. The stock was sold at an average price of $36.18, for a total transaction of $4,911,615.90. The disclosure for this sale can be found here.
Several hedge funds and other institutional investors have recently bought and sold shares of CDAY. Lee Thomas H Partners LP bought a new stake in shares of Ceridian HCM during the 2nd quarter worth $2,306,874,000. Whale Rock Capital Management LLC bought a new stake in Ceridian HCM in the second quarter worth $48,340,000. Select Equity Group L.P. lifted its stake in Ceridian HCM by 356.6% in the third quarter. Select Equity Group L.P. now owns 1,511,216 shares of the company’s stock worth $63,516,000 after purchasing an additional 1,180,249 shares during the last quarter. Capital Research Global Investors lifted its stake in Ceridian HCM by 53.7% in the third quarter. Capital Research Global Investors now owns 2,920,293 shares of the company’s stock worth $122,740,000 after purchasing an additional 1,020,293 shares during the last quarter. Finally, Fidelity National Financial Inc. bought a new stake in Ceridian HCM in the second quarter worth $33,190,000. 70.02% of the stock is owned by institutional investors.
Ceridian HCM Company Profile
Ceridian HCM Holding, Inc engages in the provision of human capital management services. It operates through Human Capital Management (HCM), and LifeWorks segments. The Human Capital Management segment includes cloud solutions, dayforce and powerplay, as well as bureau HCM solutions. The LifeWorks segment reflects the results of LifeWorks joint venture.
Recommended Story: Fundamental Analysis
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.